During the past decade, Azienda Ospedaliero-Universitaria di Modena conducted 184 clinical trials. In the 10-year time frame, 184 clinical trials started and 73 clinical trials were completed, i.e. on average, 39.7% percent of trials that started reached the finish line to date. In the past 5 years, 84 clinical trials started and 55 clinical trials were completed. i.e. 65.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliero-Universitaria di Modena" #1 sponsor was "University of Modena and Reggio Emilia" with 19 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 15 trials sponsored, "Hoffmann-La Roche" with 13 trials sponsored, "Azienda Ospedaliero-Universitaria di Modena" with 11 trials sponsored and "Gilead Sciences" with 11 trials sponsored. Other sponsors include 193 different institutions and companies that sponsored additional 117 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliero-Universitaria di Modena" #1 collaborator was "AstraZeneca" with 5 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Agenzia Italiana del Farmaco" with 2 trials as a collaborator and "Breast International Group" with 2 trials as a collaborator. Other collaborators include 82 different institutions and companies that were collaborators in the rest 83 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliero-Universitaria di Modena" are "Ulcerative Colitis" (13 trials), "Breast Cancer" (10 trials), "Ovarian Cancer" (9 trials), "Crohn's Disease" (7 trials) and "Idiopathic Pulmonary Fibrosis" (6 trials). Many other conditions were trialed in "Azienda Ospedaliero-Universitaria di Modena" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliero-Universitaria di Modena" are "Drug" (200 trials), "Other" (29 trials), "Procedure" (15 trials), "Biological" (13 trials) and "Device" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (52 trials), "Rituximab" (9 trials), "Paclitaxel" (6 trials), "Prednisone" (6 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliero-Universitaria di Modena" are 233 trials for "All" genders, 25 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 101 active trials in "Azienda Ospedaliero-Universitaria di Modena". 2 are not yet recruiting, 46 are recruiting, 52 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 102 completed trials in Azienda Ospedaliero-Universitaria di Modena, 2 suspended trials, and 33 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliero-Universitaria di Modena, 8 "Phase 1" clinical trials were conducted, 53 "Phase 2" clinical trials and 140 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 21 trials that are defined as “Not Applicable".

Azienda Ospedaliero-Universitaria di Modena has several departments that took part in Clinical trials: "Sez. di medicina Interna Oncologia ed Ematologia" - 8 trials, "Nuovo Ospedale Civile S. Agostino-Estense; Clinica Neurologica - Dipartimento di Neuroscienze" - 7 trials, "A.O. Universitaria Policlinico Di Modena; Oncologia" - 36 trials, "AOU Policlinico di Modena - Gastroenterologia" - 4 trials, "Azienda Policlinico di Modena U.O. Cardiologia, Ospedale di Modena" - 4 trials, "Ospedale Civile Di Baggiovara - U.O. Di Cardiologia" - 2 trials